Lacydyna (Lacidipine)

Lacidipine selectively blocks L‑type calcium channels on vascular smooth‑muscle cells. This inhibition prevents calcium entry that is necessary for muscle contraction, causing relaxation of arterial smooth muscle and vasodilation. The resulting fall in peripheral resistance lowers arterial pressure without markedly affecting heart rate or contractility, providing an effective antihypertensive effect.

The appropriate dose of Lacydyna is individualized by the prescribing healthcare professional based on the patient’s blood pressure, response to therapy, and any concomitant medications. Dosage adjustments are made according to clinical judgment, and patients should follow the prescriber’s instructions without altering the regimen on their own.

Safety data for lacidipine in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers typically consider alternative antihypertensives with more established safety profiles for pregnant or nursing women.

To request Lacydyna, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Both lacidipine and amlodipine belong to the dihydropyridine calcium channel blocker class and lower blood pressure by vasodilation. Lacidipine has a slightly longer half‑life and may produce a smoother 24‑hour blood pressure profile, whereas amlodipine is more widely used and has an extensive safety record. Choice between them depends on individual patient response, tolerability, and prescriber preference.

Lacydyna should be stored at ambient temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct light, and ensure the packaging remains tightly closed until use. Do not store in a refrigerator or freezer unless specifically instructed by the manufacturer.

Lacydyna is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water. Patients should follow the dosing schedule provided by their healthcare professional and avoid crushing or chewing the tablet unless instructed otherwise.

Serious adverse events, although rare, include severe hypotension, myocardial infarction, angina, hepatic dysfunction, severe allergic reactions such as anaphylaxis, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like faintness, chest pain, unusual fatigue, jaundice, rash, or irregular heartbeats while taking Lacydyna.

Lacydyna is contraindicated in patients with known hypersensitivity to lacidipine or any component of the formulation, in those with severe hypotension, cardiogenic shock, or unstable angina. Caution is also advised for individuals with significant hepatic impairment, as drug metabolism may be affected. Pregnant or nursing women should only use it when clearly indicated by a physician.